Defining comprehensive models of care for NAFLD Liver health specialists
NAFLD places a substantial burden on healthcare systems and receives little attention from public health authorities. Ambitious measures are needed to improve preparedness globally. Prof Lazarus, Spain, discusses how to establish care pathways tailored to meet patients needs but also that optimally use existing resources. Modifiable risks factors are particularly important in a comprehensive strategy.
Read MoreNAFLD prevalence in Type 1 diabetes patients
Fatty liver index and risk of hypertension
NAFLD prevalence in Type 1 diabetes patients
The authors reviewed and screened references in order to estimate NAFLD prevalence in patients with type 1 diabetes, and to explore associated characteristics and outcomes.
Read More
Fatty liver index and risk of hypertension
The authors evaluated the ability of the fatty liver index to predict the development of hypertension in healthy individuals, in a large cohort of 334,280 healthy individuals without known comorbidities.
Read MoreEmerging drugs targeting specific points in NASH pathogenesis
Review: NAFLD, driver of chronic kidney disease
Emerging drugs targeting specific points in NASH pathogenesis
Extensive research and revelation in the field of pathogenesis of NASH has offered new possibilities of treatment and emerging new drugs that are being tested currently in numerous preclinical and clinical trials.
Read More
Review: NAFLD, driver of chronic kidney disease
This narrative review by C. D. Byrne and G. Targher provides an overview of the literature.
Read More